How two proteins that bind to RNA contribute to the inflammation of asthma

Brasil Notícia Notícia

How two proteins that bind to RNA contribute to the inflammation of asthma
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 51%

A publication in Frontiers in Cell and Developmental Biology led by researchers from King's College London has, for the first time, revealed important information on the role of mRNA regulating proteins in asthma.

retrieved 26 October 2023 from https://medicalxpress.com/news/2023-10-proteins-rna-contribute-inflammation-asthma.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

medical_xpress /  🏆 101. in UK

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

HIF-2α inhibitor belzutifan significantly reduces progression of clear cell renal cell carcinomaHIF-2α inhibitor belzutifan significantly reduces progression of clear cell renal cell carcinomaBelzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer, in patients previously treated with immune checkpoint inhibitors and anti-angiogenic therapies compared with everolimus in a phase 3 clinical trial.
Consulte Mais informação »

Revolutionary approach links protein analysis and single-cell study to uncover disease mechanismsRevolutionary approach links protein analysis and single-cell study to uncover disease mechanismsIntegrated liquid-biopsy proteomics with single-cell transcriptomics from ocular cell types.
Consulte Mais informação »

Noninvasive multitarget stool RNA test found to have high sensitivity for colorectal neoplasiaNoninvasive multitarget stool RNA test found to have high sensitivity for colorectal neoplasiaA noninvasive, multitarget stool RNA (mt-sRNA) test has high sensitivity for detecting colorectal neoplasia, according to a study published online Oct. 23 in the Journal of the American Medical Association to coincide with the annual meeting of the American College of Gastroenterology, held from Oct. 20 to 25 in Vancouver, British Columbia, Canada.
Consulte Mais informação »

Researchers discover new way to trigger programmed cell death in cancer cellsResearchers discover new way to trigger programmed cell death in cancer cellsA research team from the UC Davis Comprehensive Cancer Center has identified a crucial epitope (a protein section that can activate the larger protein) on the CD95 receptor that can cause cells to die.
Consulte Mais informação »

Researchers identify 'switch' to activate cancer cell deathResearchers identify 'switch' to activate cancer cell deathA research team from the UC Davis Comprehensive Cancer Center has identified a crucial epitope (a protein section that can activate the larger protein) on the CD95 receptor that can cause cells to die. This new ability to trigger programmed cell death could open the door for improved cancer treatments. The findings were published Oct.
Consulte Mais informação »

New 'pseudo cell' formulation could revolutionize treatment of vitreoretinal diseasesNew 'pseudo cell' formulation could revolutionize treatment of vitreoretinal diseasesResearchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences and Beijing Chaoyang Hospital have developed a new 'pseudo cell' formulation based on self-healing microcapsule-loading exosomes to treat diverse vitreoretinal diseases.
Consulte Mais informação »



Render Time: 2025-03-01 00:28:06